Latest / The Cracking Cancer Podcast
IV or Subcutaneous Injection - What’s the Difference? With Jeanne Szurek and Dr. Rob Swanda. Episode 57.
In this episode of Cracking Cancer, host Dr. Kyle Concannon is joined by Jeanne Zurek, a Stage IV EGFR-mutated non-small cell lung cancer patient from Minnesota, and science communicator Rob Swanda, PhD. The episode focuses on how the route of drug administration impacts a patient's quality of life, moving from oral TKIs to intravenous (IV) infusions and, ultimately, to subcutaneous (SubQ) injections.
Jeanne shares their personal experience transitioning from hours-long IV infusions of amivantamab—which frequently triggered infusion reactions and required heavy steroid pre-medications—to a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.